A detailed history of Princeton Global Asset Management LLC transactions in Biotricity Inc. stock. As of the latest transaction made, Princeton Global Asset Management LLC holds 834 shares of BTCY stock, worth $750. This represents 0.0% of its overall portfolio holdings.

Number of Shares
834
Previous 834 -0.0%
Holding current value
$750
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

SELL
$1.9 - $3.27 $7,915 - $13,622
-4,166 Reduced 83.32%
834 $1,000
Q1 2023

Apr 20, 2023

BUY
$0.44 - $0.88 $2,200 - $4,400
5,000 New
5,000 $2,000

Others Institutions Holding BTCY

# of Institutions
2
Shares Held
857
Call Options Held
0
Put Options Held
0

About BIOTRICITY INC.


  • Ticker BTCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 50,431,200
  • Market Cap $45.4M
  • Description
  • Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile ...
More about BTCY
Track This Portfolio

Track Princeton Global Asset Management LLC Portfolio

Follow Princeton Global Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Global Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Global Asset Management LLC with notifications on news.